Groupe Bruxelles Lambert completed the acquisition of a majority stake in Affidea from B-Flexion for $1.08bn.

Groupe Bruxelles Lambert, an investment holding company, completed the acquisition of a majority stake in Affidea, a provider of medical diagnostic services serving private health insurers, patients, doctors and NHS across Europe, from B-Flexion, a private investment firm, for $1.08bn. “We have benefitted greatly from B-Flexion’s deep strategic insights and experience to scale our dynamic organisation and achieve stellar growth almost doubling the size of the business in the last 4 years, while consolidating the markets with under-served private healthcare services. In GBL, we have another partner with a long-term outlook who shares our values and has a commitment to clinical excellence," Giuseppe Recchi, Affidea CEO.